{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T20:55:54Z","timestamp":1780433754531,"version":"3.54.1"},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,4]]},"abstract":"<jats:p>Resistant and refractory cytomegalovirus (CMV) viremia can limit the provision of chemotherapy due to myelosuppression and end-organ dysfunction. Few therapies are available for children with clinically significant CMV viremia. We successfully used maribavir for a 4-year-old patient with lymphoma to complete his chemotherapy course. Resistance to maribavir did result after many months of therapy.<\/jats:p>","DOI":"10.1097\/mph.0000000000002841","type":"journal-article","created":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T16:01:31Z","timestamp":1709740891000},"page":"e244-e247","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":9,"title":["Use of Maribavir for Multidrug Resistant Cytomegaloviremia in a Pediatric Oncology Patient"],"prefix":"10.1097","volume":"46","author":[{"given":"James E.","family":"Fisher","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Penn State College of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Mulieri","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Penn State Milton S Hershey Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Finch","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Penn State College of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica E.","family":"Ericson","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Penn State College of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,3,1]]},"reference":[{"key":"R1-20250804","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/MPH.0000000000000298","article-title":"Cytomegalovirus disease in children with acute lymphoblastic leukemia in the nontransplant setting: case series and review of the literature","volume":"37","author":"Rahbarimanesh","year":"2015","journal-title":"J Pediatr Hematol Oncol"},{"key":"R2-20250804","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.1182\/blood.V96.9.3286","article-title":"Drug-resistant human cytomegalovirus infection in children after allogeneic stem cell transplantation may have different clinical outcomes","volume":"96","author":"Eckle","year":"2000","journal-title":"Blood"},{"key":"R3-20250804","doi-asserted-by":"crossref","first-page":"ofab639","DOI":"10.1093\/ofid\/ofab639","article-title":"Risk factors for CMV viremia and treatment-associated adverse events among pediatric hematopoietic stem cell transplant recipients","volume":"9","author":"Heston","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"R4-20250804","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.3389\/fmicb.2016.01317","article-title":"Detection of low frequency multi-drug resistance and novel putative maribavir resistance in immunocompromised pediatric patients with cytomegalovirus","volume":"7","author":"Houldcroft","year":"2016","journal-title":"Front Microbiol"},{"key":"R5-20250804","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/rmv.615","article-title":"Function of human cytomegalovirus UL97 kinase in viral infection and its inhibition by maribavir","volume":"19","author":"Prichard","year":"2009","journal-title":"Rev Med Virol"},{"key":"R6-20250804","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1093\/cid\/ciab988","article-title":"Maribavir for refractory cytomegalovirus infections with or without resistance post-transplant: results from a phase 3 randomized clinical trial","volume":"75","author":"Avery","year":"2022","journal-title":"Clin Infect Dis"},{"key":"R7-20250804","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1093\/cid\/ciy706","article-title":"Maribavir for refractory or resistant cytomegalovirus infections in hematopoietic-cell or solid-organ transplant recipients: a randomized, dose-ranging, double-blind, phase 2 study","volume":"68","author":"Papanicolaou","year":"2019","journal-title":"Clin Infect Dis"},{"key":"R8-20250804","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/psp4.12943","article-title":"Population pharmacokinetic modeling and simulation of maribavir to support dose selection and regulatory approval in adolescents with posttransplant refractory cytomegalovirus","volume":"12","author":"Sun","year":"2023","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"R9-20250804","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.antiviral.2019.01.011","article-title":"Clinical development of letermovir and maribavir: overview of human cytomegalovirus drug resistance","volume":"163","author":"Piret","year":"2019","journal-title":"Antiviral Res"},{"key":"R10-20250804","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jcv.2007.07.003","article-title":"Emergence and persistence of multiple antiviral-resistant CMV strains in a highly immunocompromised child","volume":"40","author":"Iwasenko","year":"2007","journal-title":"J Clin Virol"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002841","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T20:02:30Z","timestamp":1754337750000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002841"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,1]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000002841","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3,1]]},"assertion":[{"value":"2023-09-01","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-02-01","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}